Table 4 Histologic characteristics of HBV-infected patients with and without hepatic steatosis after PSM
|  | HBV infection (N = 254) | HBV infection + NAFLD (N = 254) | P value |
|---|---|---|---|
Steatosis |  |  | < 0.001 |
0 | 254 (100%) | 0 | |
1 | 0 | 218 (85.83%) | |
2 | 0 | 33 (12.99%) | |
3 | 0 | 3 (1.18%) | |
Lobular inflammation |  |  | < 0.001 |
0 | 1 (0.39%) | 0 | |
1 | 193 (75.98%) | 150 (59.06%) | |
2 | 59 (23.23%) | 92 (36.22%) | |
3 | 1 (0.39%) | 12 (4.72%) | |
4 | 0 | 0 | |
Portal inflammation |  |  | < 0.001 |
1 | 165 (64.96%) | 100 (39.37%) | |
2 | 81 (31.89%) | 127 (50.00%) | |
3 | 8 (3.15%) | 26 (10.24%) | |
4 | 0 | 1 (0.39%) | |
Hepatic ballooning | Â | Â | 0.001 |
0 | 253 (99.61%) | 238 (93.70%) | |
1 | 1 (0.39%) | 9 (3.54%) | |
2 | 0 | 7 (2.76%) | |
3 | 0 | 0 | |
G |  |  | < 0.001 |
1 | 148 (58.27%) | 92 (36.22%) | |
2 | 98 (38.58%) | 134 (52.76%) | |
3 | 8 (3.15%) | 27 (10.63%) | |
4 | 0 | 1 (0.39%) | |
S | Â | Â | 0.010 |
0 | 9 (3.54%) | 0 | |
1 | 105 (41.34%) | 97 (38.19%) | |
2 | 100 (39.37%) | 97 (38.19%) | |
3 | 20 (7.87%) | 29 (11.42%) | |
4 | 20 (7.87%) | 31 (12.20%) | |
Significant liver fibrosis | 140 (55.12%) | 157 (61.81%) | 0.126 |
Advanced liver fibrosis | 40 (15.75%) | 60 (23.62%) | 0.034 |
Significant liver inflammation | 106 (41.73%) | 162 (63.78%) | < 0.001 |